Side-by-side
Pick up to 3 peptides and see their key facts side by side. Useful for narrowing a search before deciding which page to read in full.
1 of 3 selected.
| Field | Last updated |
|---|---|
| Aliases | N-Acetyl Semax amidate, Acetylated Semax, Ac-Semax, Semax analog |
| Category | Cognitive & Nootropic |
| Formula | C₃₉H₅₃N₉O₁₁S |
| Molecular weight | 855.97 Da |
| Half-life | ~hours (acetylated; longer than Semax) |
| Mechanism (summary) | In research catalogs, this compound is usually called N-Acetyl Semax amidate — a modified version of Semax (an ACTH(4-10)-derived heptapeptide). PubChem identifies the modified molecule, but indexed clinical evidence for the modified form is limited. Most meaningful biological and clinical discussion still comes from the parent peptide Semax. |
| Dosing notes | There is no standardized human dosing for N-Acetyl Semax. Parent-Semax regimens reported in the literature are intranasal and indication-specific: 6,000 mcg/day for 10 days, or acute-stroke 12 mg/day or 18 mg/day. |
| Storage | No approved label exists with product-specific N-Acetyl Semax storage instructions. Default synthetic-peptide handling: frozen, dry, light-protected lyophilized storage; careful aliquoting after reconstitution. |
|---|
| Read more | Full reference → |
|---|